期刊
ONCOIMMUNOLOGY
卷 3, 期 8, 页码 -出版社
LANDES BIOSCIENCE
DOI: 10.4161/21624011.2014.954832
关键词
dendritic cells; immunotherapy; vaccine
Targeting antigens directly to dendritic cells (DCs) in situ has emerged as a promising strategy to potentiate immunity. A recent clinical trial of antibody-mediated targeting of tumor antigen NY-ESO1 to the DC receptor DEC-205 demonstrated an induction of strong cellular and humoral responses. Recent studies with DC-targeting via nanoparticles suggest that combinatorial targeting of multiple human DC subsets may further improve the efficacy of DC targeting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据